The U.S. hospice market size was exhibited at USD 30.25 billion in 2024 and is projected to hit around USD 47.52 billion by 2034, growing at a CAGR of 4.62% during the forecast period 2025 to 2034.
Report Coverage | Details |
Market Size in 2025 | USD 31.65 Billion |
Market Size by 2034 | USD 47.52 Billion |
Growth Rate From 2025 to 2034 | CAGR of 4.62% |
Base Year | 2024 |
Forecast Period | 2025-2034 |
Segments Covered | Type, Location, Diagnosis |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Key Companies Profiled | Chemed Corporation (VITAS Healthcare); LHC Group, Inc. (UnitedHealth Group); Amedisys; Gentiva; Brookdale Senior Living, Inc; Crossroads Hospice (Agape Care Group); Seasons Hospice; Oklahoma Palliative & Hospice Care; Compassus; Chapters Health System |
The growth of the market is attributed to the rising prevalence of chronic diseases among rapidly growing geriatric populations. In addition, increasing need for quality healthcare services at home along with growing Medicare reimbursement for hospice care is expected to further drive the market growth over the forecast period.
The geriatric population is predicted to grow considerably in the future as life expectancy increases. However, this growing population leads to a higher prevalence of chronic conditions such as cancer, dementia, and cardiovascular diseases. These conditions often necessitate specialized end-of-life care, which is effectively provided by hospice services. For instance, according to the National Hospice and Palliative Care Organization (NHPCO), in 2021, about 47.8% of Medicare hospice patients were aged 75 and above. However, the 85 and older age category has climbed the highest since 60.8%.
The number of hospice centers in the U.S. has been steadily increasing over the years. According to the Biennial Overview of Post-acute and Long-term Care in the United States, as of 2020, there were approximately 5,200 hospice care agencies operating in the U.S. In 2022, this number amplified to 5,899 Medicare-certified hospice agencies. This growth is largely attributed to the aging population and an increasing prevalence of chronic diseases, which drive demand for hospice services. Moreover, the market is experiencing a significant shift towards home-based care, driven by technological advancements and evolving patient preferences. Remote patient monitoring tools and telehealth services enable healthcare providers to deliver effective care without requiring patients to leave their homes. These innovations improve care quality and reduce hospital stay costs, making home-based hospice care an attractive option for many families.
Furthermore, the growing awareness of end-of-life care options, particularly hospice care, has significantly influenced its utilization in the U.S. This trend is driven by several factors, including public perceptions, healthcare system dynamics, and the evolving reform for hospice care. As awareness of hospice benefits increases, healthcare providers are more expected to recommend hospice services to patients and families. Organizations such as the National Hospice and Palliative Care Organization (NHPCO) are organizing awareness campaigns that focus on educating both patients and healthcare providers. For instance, the Palliative Care Awareness Campaign initiative provides resources to empower patients and caregivers, emphasizing the importance of integrating palliative care early in treatment rather than associating it solely with end-of-life scenarios. Thus, as awareness continues to increase, it is expected that hospice care will become an even more integral part of end-of-life planning for many Americans.
Based on type, Routine Homecare (RHC) segment dominated the market in 2024 and accounted for the largest revenue share of 92.98%. This growth can be attributed to various factors, such as favorable reimbursement policies and increased comfort. RHC is paid under Medicare for each day till the patient is under the hospice program. Furthermore, it involves regular visits by registered nurses, hospice physicians, and hospice aids to patient locations. It provides advantages of companionship, family involvement, constant attention, and more.
The inpatient respite care segment is expected to grow at the fastest CAGR from 2025 to 2034. Inpatient Respite Care (IRC) intends to provide temporary or short-term relief to primary care providers. The patient temporarily stays in inpatient hospice centers, such as assisted living facilities or nursing homes, to give primary caregivers a break. This enables primary caregivers to reduce burnout and work efficiently. Recent initiatives in inpatient respite care within U.S. hospice settings are focused on enhancing support for caregivers and addressing the growing demand for specialized care, particularly for patients with dementia and other complex needs.
The hospice center segment held the largest market share of 86.32% in 2024, owing to the various benefits offered by these facilities. These centers prevent the need for hospitalization and offer more balanced & controlled care settings. In addition, growing awareness regarding various advantages, such as 24/7 availability of professional care and emotional support from family members is projected to propel market growth. Many service providers offer hospice inpatient facilities. Hospice centers can be helpful to patients who need round-the-clock care or do not have a caregiver. Rising demand for respite care in order to give personal space to the primary caregiver is contributing to segment growth.
The skilled nursing facility segment is anticipated to grow at the fastest CAGR during the forecast period. High-quality nursing services provided in skilled nursing facilities and increasing occupancy are among factors expected to drive segment growth. Apart from hospitals, skilled nursing facilities have the capability to offer comprehensive care. A rising geriatric population and improving access to skilled nursing facilities owing to supportive reimbursement framework are some of the factors anticipated to drive market growth in the coming years.
The dementia segment held the largest market share of 26.0% in 2024, owing to the dependency and disability among the elderly, with significant physical and psychological effects on individuals, their families, and caregivers. The rising prevalence of dementia, coupled with an aging population, is driving growth in this segment. According to the Alzheimer’s Association, nearly 7 million Americans currently live with Alzheimer’s disease, a figure expected to increase to approximately 13 million by 2050. In 2021, Alzheimer’s disease ranked as the fifth-leading cause of death among individuals aged 65 and older. In addition, health and long-term care costs for dementia patients are projected to reach USD 360 billion in 2024, escalating to nearly USD 1 trillion by 2050.
The cancer segment is expected to grow significantly over the forecast period. This growth can be attributed to the rising number of cancer diagnoses and the increasing need for palliative care services. Hospice care plays a vital role in managing cancer symptoms, alleviating treatment-related side effects, and ensuring comfort and dignity for patients during the final stages of life. In 2024, the National Cancer Institute estimates that 2,001,140 new cancer cases will be diagnosed in the U.S., with 611,720 deaths expected. Prostate, lung, and colorectal cancers are projected to account for 48% of all new cancer cases in men, while breast, lung, and colorectal cancers will make up 51% of diagnoses among women.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. hospice market
By Type
By Location
By Diagnosis
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Location Segment
1.2.3. Diagnosis Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. U.S. Hospice Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increased awareness of end-of-life care
3.2.1.2. Rising preference for home-based care
3.2.1.3. Rising geriatric population
3.2.1.4. Growing prevalence of chronic conditions
3.2.1.5. Increasing number of hospice centers
3.2.2. Market restraint analysis
3.2.2.1. Underutilization of hospice services among population
3.2.2.2. Shortage of workforce
3.2.3. Industry challenges analysis
3.2.3.1. Correct documentation
3.2.3.2. Misconceptions & late referrals
3.2.4. Industry opportunity analysis
3.2.4.1. Initiatives by hospice care centers
3.2.4.2. Adoption of new technologies
3.3. Regulatory Framework & Reimbursement Scenario
3.4. State-wise Performance Metrics in Hospice Care Delivery in the U.S.
3.5. U.S. Hospice Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.2.4. Environmental Landscape
3.5.2.5. Legal Landscape
3.5.2.6. Social Landscape
Chapter 4. U.S. Hospice Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Hospice Market Type Movement Analysis
4.3. U.S. Hospice Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Routine Home Care
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Continuous Home Care
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Inpatient Respite Care
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. General Inpatient Care
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Hospice Market: Location Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Hospice Market Location Movement Analysis
5.3. U.S. Hospice Market Size & Trend Analysis, by Location, 2018 to 2030 (USD Million)
5.4. Hospice Center
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Hospital
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Home Hospice Care
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Skilled Nursing Facility
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Hospice Market: Diagnosis Model Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Hospice Market Diagnosis Movement Analysis
6.3. U.S. Hospice Market Size & Trend Analysis, by Diagnosis, 2018 to 2030 (USD Million)
6.4. Dementia
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Circulatory/Heart
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Cancer
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Respiratory
6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Stroke
6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.9. Chronic Kidney Disease
6.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.10. Others
6.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2024
7.4. Company Profiles/Listing
7.4.1. Chemed Corporation (VITAS Healthcare)
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Service benchmarking
7.4.1.4. Strategic initiatives
7.4.2. LHC Group, Inc. (UnitedHealth Group)
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Service benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Amedisys
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Service benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Gentiva
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Service benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Brookdale Senior Living, Inc
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Service benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Crossroads Hospice (Agape Care Group)
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Service benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Seasons Hospice
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Service benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Oklahoma Palliative & Hospice Care
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Service benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Compassus
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Service benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Chapters Health System
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Service benchmarking
7.4.10.4. Strategic initiatives